Insider · CIK 0001316746

Riehle J Nick

Reports to the SEC for 4 companies · CHARLOTTE, NC

sec.gov

Transactions

Companies

Filings

CIK

0001316746

Forms 4 and 5

Insider transactions

15 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-09-08	APTNADAPTIN BIO, INC. · Stock Option (right to buy)A Award	Director	AAward	+110K sh	—	—	109,847
2017-06-19	Athenex, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+120K sh	—	—	120,000
2017-06-19	Athenex, Inc.P Purchase	Chief Financial Officer	PPurchase	+1,500 sh	$11.00	+$16.5K	1,500
2017-06-13	Athenex, Inc.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+120K sh	—	—	120,000
2014-01-22	Chelsea Therapeutics International, Ltd.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+50K sh	—	—	50,000
2013-01-07	Chelsea Therapeutics International, Ltd.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+50K sh	—	—	50,000
2012-07-09	Chelsea Therapeutics International, Ltd.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+50K sh	—	—	50,000
2012-01-25	Chelsea Therapeutics International, Ltd.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+50K sh	—	—	50,000
2011-01-11	Chelsea Therapeutics International, Ltd.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+50K sh	—	—	50,000
2010-11-04	Chelsea Therapeutics International, Ltd.P Purchase	Chief Financial Officer	PPurchase	+3,000 sh	$4.83	+$14.5K	66,183
2010-01-19	Chelsea Therapeutics International, Ltd.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+50K sh	—	—	50,000
2009-12-21	Chelsea Therapeutics International, Ltd.P Purchase	Chief Financial Officer	PPurchase	+2,500 sh	$2.20	+$5,500	63,183
2009-01-22	Chelsea Therapeutics International, Ltd.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+50K sh	—	—	50,000
2005-08-25	Chelsea Therapeutics International, Ltd.Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−14.7K sh	—	—	44,020
2005-08-25	Chelsea Therapeutics International, Ltd.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+14.7K sh	$0.07	+$1,000.017	14,663

Recent filings

Accepted (ET)
Sep 104
Riehle J Nick0001213900-25-086586
SEC(opens sec.gov)
Aug 214/A
Riehle J Nick0001209191-18-047824
SEC(opens sec.gov)
Jul 284/A
Riehle J Nick0000905148-17-000704
SEC(opens sec.gov)
Jun 214
Athenex, Inc.0000905148-17-000607
SEC(opens sec.gov)
Jan 244
Chelsea Therapeutics International, Ltd.0001144204-14-004046
SEC(opens sec.gov)
Jan 94
Riehle J Nick0001144204-13-001563
SEC(opens sec.gov)
Jul 114
Riehle J Nick0001181431-12-040448
SEC(opens sec.gov)
Jan 274
Riehle J Nick0001181431-12-004232
SEC(opens sec.gov)
Jan 134
Riehle J Nick0001181431-11-003539
SEC(opens sec.gov)
Nov 54
Riehle J Nick0001181431-10-053749
SEC(opens sec.gov)
Jan 214
Riehle J Nick0001181431-10-004165
SEC(opens sec.gov)
Dec 224
Riehle J Nick0001181431-09-058119
SEC(opens sec.gov)
Jan 264
Riehle J Nick0001181431-09-004803
SEC(opens sec.gov)
Aug 294
Chelsea Therapeutics International, Ltd.0001181431-05-049299
SEC(opens sec.gov)

Companies

Address

3530 TORINGDON WAY SUITE 200

CHARLOTTE, NC, 28277